Columbia Laboratories, Inc.
EX-4.10 2 exhibit410.htm EXHIBIT 4.10 exhibit410.htm
Exhibit 4.10
| Columbia Laboratories, Inc. | |||||||||
| 2008 | |||||||||
| Name: | |||||||||
| Address: | |||||||||
| City & State: | |||||||||
| Grant Number: | Grant Date: | /2008 | Yearly Vesting Schedule | ||||||
| Beginning | Percent | Shares | |||||||
| Option Type: | ISO or NQSO | Shares Granted: | Year 1 | 25% | 25,000 | ||||
| Year 2 | 25% | 25,000 | |||||||
| Grant Price: | Year 3 | 25% | 25,000 | ||||||
| Year 4 | 25% | 25,000 | |||||||
| Vesting Update: | /09 @ 25.00% | Expiration Date: | /2015 | ||||||
| NOTICE OF GRANT OF A STOCK OPTION FOR THE | |||||||||
| PURCHASE OF SHARES OF THE COMMON STOCK OF | |||||||||
| Columbia Laboratories, Inc. | |||||||||
| Robert S. Mills or James A. Meer | |||||||||
| CEO / President/ Sr. Vice President CFO & Treasurer | |||||||||
| By affixing your signature to this Notice, you acknowledge receipt of a copy of the Agreement and the Plan to which the Agreement and this Stock Option Grant is subject and agree that the Options Granted hereunder shall be subject to such Plan and Agreement and shall be governed by their terms and provisions. | |||||||||
| ___________________________ | ___________ | ||||||||
| Name: | Date | ||||||||
